ArticleNature communications2017

THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.

Florencia Cayrol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.